(VRA) Vera Bradley - Overview
Stock: Handbags, Travel, Accessories, Home, Jewelry
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 81.1% |
| Relative Tail Risk | -13.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.05 |
| Alpha | -48.44 |
| Character TTM | |
|---|---|
| Beta | 1.541 |
| Beta Downside | 1.254 |
| Drawdowns 3y | |
|---|---|
| Max DD | 78.80% |
| CAGR/Max DD | -0.29 |
Description: VRA Vera Bradley January 25, 2026
Vera Bradley, Inc. (NASDAQ: VRA) designs, manufactures, and sells a broad portfolio of women’s handbags, travel goods, fashion accessories, home items, and licensed merchandise primarily in the United States. The business is organized into three reporting segments: Vera Bradley Direct (company-owned stores and e-commerce), Vera Bradley Indirect (wholesale and third-party channels), and Pura Vida (bracelets and related accessories sold through wholesale and its own website).
In the most recent fiscal quarter (Q2 2024), the company reported net sales of $327 million, a 6 % year-over-year increase driven largely by a 12 % rise in e-commerce revenue and a 4 % lift in comparable sales at its full-line stores. Inventory turnover improved to 4.2 ×, reflecting tighter supply-chain management, while the operating margin held at roughly 8.5 % (≈ $28 million operating income). The balance sheet remains strong, with a cash-to-debt ratio of 1.3 × and a current ratio of 1.9 ×, giving the firm flexibility to fund store expansions or marketing initiatives.
Key macro-economic drivers for Vera Bradley include consumer discretionary spending trends and inflation-adjusted disposable income. The U.S. personal consumption expenditures price index has been rising at a 3-4 % annual rate, which can compress demand for non-essential accessories, but the brand’s positioning as an affordable-luxury option tends to perform better than higher-priced luxury peers when inflation pressures tighten household budgets. Additionally, the broader apparel and accessories sector is experiencing a shift toward “experience-focused” retail-e.g., in-store events and limited-edition collaborations-which Vera Bradley leverages through its annual Fort Wayne outlet sale and seasonal product drops.
From a valuation standpoint, the stock trades at a forward price-to-earnings multiple of ~ 12×, modestly below the GICS sub-industry average of 14×, while its free-cash-flow yield sits near 5 %, suggesting a relative discount but also indicating that the market may be pricing in execution risk around store-level sales growth.
For a deeper, data-driven assessment of VRA’s intrinsic value, the ValueRay platform provides a granular model you may want to explore.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -105.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.14 > 0.02 and ΔFCF/TA -17.26 > 1.0 |
| NWC/Revenue: 25.93% < 20% (prev 35.38%; Δ -9.45% < -1%) |
| CFO/TA -0.10 > 3% & CFO -24.2m > Net Income -105.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.52 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.9m) vs 12m ago -6.31% < -2% |
| Gross Margin: 46.54% > 18% (prev 0.52%; Δ 4602 % > 0.5%) |
| Asset Turnover: 91.30% > 50% (prev 108.2%; Δ -16.87% > 0%) |
| Interest Coverage Ratio: -390.2 > 6 (EBITDA TTM -22.6m / Interest Expense TTM 135.0k) |
Altman Z'' 4.66
| A: 0.30 (Total Current Assets 122.3m - Total Current Liabilities 48.6m) / Total Assets 243.7m |
| B: 0.70 (Retained Earnings 169.8m / Total Assets 243.7m) |
| C: -0.17 (EBIT TTM -52.7m / Avg Total Assets 311.4m) |
| D: 1.47 (Book Value of Equity 169.7m / Total Liabilities 115.6m) |
| Altman-Z'' Score: 4.66 = AA |
Beneish M -4.00
| DSRI: 0.88 (Receivables 19.4m/31.6m, Revenue 284.4m/410.2m) |
| GMI: 1.12 (GM 46.54% / 52.02%) |
| AQI: 0.22 (AQ_t 0.02 / AQ_t-1 0.10) |
| SGI: 0.69 (Revenue 284.4m / 410.2m) |
| TATA: -0.33 (NI -105.6m - CFO -24.2m) / TA 243.7m) |
| Beneish M-Score: -4.04 (Cap -4..+1) = AAA |
What is the price of VRA shares?
Over the past week, the price has changed by +10.30%, over one month by -9.82%, over three months by +4.90% and over the past year by -29.01%.
Is VRA a buy, sell or hold?
What are the forecasts/targets for the VRA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 4 | 55.6% |
| Analysts Target Price | 4 | 55.6% |
| ValueRay Target Price | 2.2 | -14% |
VRA Fundamental Data Overview February 03, 2026
P/S = 0.219
P/B = 0.525
P/EG = 1.31
Revenue TTM = 284.4m USD
EBIT TTM = -52.7m USD
EBITDA TTM = -22.6m USD
Long Term Debt = 10.0m USD (from longTermDebt, last quarter)
Short Term Debt = 19.5m USD (from shortTermDebt, last quarter)
Debt = 86.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 75.7m USD (from netDebt column, last quarter)
Enterprise Value = 155.0m USD (79.3m + Debt 86.4m - CCE 10.7m)
Interest Coverage Ratio = -390.2 (Ebit TTM -52.7m / Interest Expense TTM 135.0k)
EV/FCF = -4.62x (Enterprise Value 155.0m / FCF TTM -33.6m)
FCF Yield = -21.67% (FCF TTM -33.6m / Enterprise Value 155.0m)
FCF Margin = -11.81% (FCF TTM -33.6m / Revenue TTM 284.4m)
Net Margin = -37.14% (Net Income TTM -105.6m / Revenue TTM 284.4m)
Gross Margin = 46.54% ((Revenue TTM 284.4m - Cost of Revenue TTM 152.0m) / Revenue TTM)
Gross Margin QoQ = 42.06% (prev 44.08%)
Tobins Q-Ratio = 0.64 (Enterprise Value 155.0m / Total Assets 243.7m)
Interest Expense / Debt = 0.16% (Interest Expense 135.0k / Debt 86.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = -41.6m (EBIT -52.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.52 (Total Current Assets 122.3m / Total Current Liabilities 48.6m)
Debt / Equity = 0.67 (Debt 86.4m / totalStockholderEquity, last quarter 128.1m)
Debt / EBITDA = -3.35 (negative EBITDA) (Net Debt 75.7m / EBITDA -22.6m)
Debt / FCF = -2.25 (negative FCF - burning cash) (Net Debt 75.7m / FCF TTM -33.6m)
Total Stockholder Equity = 169.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -33.91% (Net Income -105.6m / Total Assets 243.7m)
RoE = -62.28% (Net Income TTM -105.6m / Total Stockholder Equity 169.6m)
RoCE = -29.33% (EBIT -52.7m / Capital Employed (Equity 169.6m + L.T.Debt 10.0m))
RoIC = -27.13% (negative operating profit) (NOPAT -41.6m / Invested Capital 153.4m)
WACC = 5.61% (E(79.3m)/V(165.8m) * Re(11.59%) + D(86.4m)/V(165.8m) * Rd(0.16%) * (1-Tc(0.21)))
Discount Rate = 11.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.45%
Fair Price DCF = unknown (Cash Flow -33.6m)
EPS Correlation: -70.57 | EPS CAGR: -40.28% | SUE: -0.95 | # QB: 0
Revenue Correlation: -75.83 | Revenue CAGR: -18.61% | SUE: N/A | # QB: 0
EPS next Year (2027-01-31): EPS=0.05 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+110.4% | Growth Revenue=+2.3%